THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT

THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT

Parathyroid carcinoma (PC) is a rare neoplasm with a prevalence of only 0.005 % of all malignancies, and less than 1 % among patients with primary hyperparathyroidism. The diagnosis can be challenging due to the rarity of the disease, similarity of clinical features to parathyroid adenoma, and lack...

Full description

Bibliographic Details
Main Authors: V. A. Gorbunova, E. A. Pigarova, L. Ya. Rozhinskaya, I. A. Voronkova, Yu. A. Krupinova, G. S. Emel’yanova, L. S. Kruglova, S. V. Shiryaev, M. B. Dolgushin, M. E. Bilik, E. A. Kobyakova, D. V. Komov
Format: Article
Language:Russian
Published: ABV-press 2017-04-01
Series:Opuholi Golovy i Šei
Subjects:
parathyroid carcinoma
lung metastases
primary hyperparathyroidism
hypercalcemia
multikinase inhibitors
sorafenib
Online Access:https://ogsh.abvpress.ru/jour/article/view/254

Internet

https://ogsh.abvpress.ru/jour/article/view/254

Similar Items